Andrographis
Andrographis is a bitter herb from South and Southeast Asian traditions, studied in the context of upper respiratory symptoms and immune-related research.
Overview
Andrographis (Andrographis paniculata) is a bitter-tasting herbaceous plant native to South and Southeast Asia, where it has been a component of traditional medicine systems for centuries. In Ayurvedic tradition it is known as "kalmegh" or "king of bitters" — a name that reflects both its intensely bitter flavor and its prominent position in Indian herbal pharmacopeias. In Western markets, andrographis has gained visibility primarily through its inclusion in cold-season and immune-support supplement formulations, where it is often combined with other botanicals. The plant's reputation in the supplement industry substantially exceeds the certainty of its evidence base, a pattern common among botanicals that have crossed from traditional medicine contexts into commercial wellness products. This page is educational and does not recommend use for any condition.
The modern commercial framing of andrographis as a "cold and flu herb" represents a significant narrowing of the plant's broader traditional profile, driven by a handful of clinical trials examining upper respiratory outcomes and by the commercial incentives of the supplement market. This selective repackaging is not inaccurate — respiratory contexts do appear in the traditional literature — but it captures only a fraction of the plant's historical use across multiple traditional systems.
What it is
Andrographis paniculata is an annual plant in the family Acanthaceae, growing in tropical and subtropical regions across India, Sri Lanka, China, and Southeast Asia. The aerial parts — stems and leaves — are the portions most commonly used in traditional preparations and modern supplements. The compound most frequently discussed in the research literature is andrographolide, a diterpene lactone that has been the primary focus of pharmacological investigation. Other related compounds, including neoandrographolide and dehydroandrographolide, are also present in the plant but have received less research attention.
Commercial andrographis products appear in several forms: dried herb preparations, standardized extracts (typically concentrated for andrographolide content), tablets, capsules, and combination formulations that pair andrographis with other botanicals such as eleuthero or echinacea. The distinction between whole-herb preparations and standardized extracts is significant, as the concentration of key compounds differs substantially between these formats. Products labeled as "standardized" typically specify a target andrographolide content, though the actual levels present can vary between brands and production batches.
Traditional use (educational)
Andrographis holds a long-established position in Ayurvedic medicine, where it has been classified as a bitter tonic and referenced across a range of traditional applications — particularly those involving digestive, respiratory, and liver-related contexts. In Traditional Chinese Medicine, the plant is known as "chuanxinlian" and has been included in classical formulas for centuries, typically combined with other herbs within the framework of multi-component prescriptions. Southeast Asian traditional medicine systems — in Thailand, Malaysia, and Indonesia among others — have also incorporated andrographis, where it is sometimes prepared as a decoction or consumed in its raw form.
The traditional framing of andrographis across these systems is characteristically holistic: the plant was understood within broader constitutional and environmental frameworks rather than as a targeted single-purpose intervention. The modern repackaging of andrographis as primarily a cold-season supplement represents a commercially driven recontextualization that, while drawing on genuine traditional associations, compresses a wide traditional profile into a narrow commercial niche. Respiratory and fever-related associations do appear consistently in the traditional literature across multiple systems, but they sit alongside a much broader range of traditional contexts that the supplement market largely ignores.
What research says
The clinical research on andrographis is concentrated primarily in the area of upper respiratory tract symptoms, with a smaller body of work addressing other applications. Several randomized controlled trials, conducted mainly in Scandinavian and Southeast Asian populations, have examined andrographis preparations — sometimes in combination with eleuthero — in the context of common cold symptoms. Some of these trials reported statistically significant differences in symptom severity or duration between andrographis groups and placebo, while others produced less definitive results.
Systematic reviews examining this trial evidence have noted that while some individual trials show favorable results, the overall quality of the evidence is constrained by small sample sizes, methodological variability, and limited demographic diversity. The available data are generally characterized as suggestive but insufficient for firm conclusions — a qualified assessment typical of the evidence landscape for many traditional botanicals that have been evaluated in a small number of modern trials.
Beyond upper respiratory research, preliminary laboratory and animal studies have explored andrographolide's interactions with various biological pathways, including inflammatory signaling cascades and cellular proliferation models. These mechanistic investigations are early-stage and do not translate directly to clinical applications in humans. The broader evidence base for andrographis remains thin relative to its commercial prominence, and the distance between what has been observed in controlled experimental settings and what can be confidently stated about its effects in everyday use is substantial.
Safety & interactions
Andrographis preparations have been associated with several adverse effects in published trial and post-marketing literature, though serious events appear to be uncommon. Systematic reviews of the safety literature report that adverse events are mostly mild and gastrointestinal in nature. The most frequently reported side effects in clinical trials include gastrointestinal discomfort — nausea, vomiting, and stomach upset — consistent with the plant's intensely bitter character. Some reports have also noted headache, fatigue, and skin rash in a minority of participants.
A potentially significant safety consideration involves andrographis and anticoagulant or antiplatelet medications. Preliminary evidence, primarily from in vitro and animal studies, suggests that andrographolide may have antiplatelet properties, raising theoretical concerns about additive effects when combined with blood-thinning medications. This interaction is not conclusively established in human studies but is commonly flagged in reference materials as a precautionary consideration. Some sources also note theoretical interactions with medications affecting blood pressure and immune function, though these concerns rest on pharmacological reasoning rather than documented clinical cases.
Who should be cautious
Pregnant individuals should avoid andrographis. Traditional medicine texts and some preliminary research have raised concerns about potential effects on reproductive function, and the compound is commonly listed as contraindicated during pregnancy in herbal reference materials. Breastfeeding individuals face a similar precautionary recommendation given the absence of safety data for this population. Individuals with autoimmune conditions may wish to exercise caution, as some preliminary research has explored andrographolide's effects on immune pathway signaling — a context that introduces theoretical uncertainty for people managing conditions involving immune dysregulation.
People scheduled for surgical procedures should be aware of the theoretical antiplatelet concerns and may wish to discontinue use well in advance, in consultation with their healthcare team. Individuals with low blood pressure or those taking antihypertensive medications should also note that some reference materials mention potential blood pressure-related effects, though the clinical significance of this concern remains poorly characterized in the published literature.
Quality & sourcing considerations
The andrographis supplement market exhibits the quality variability common to botanical products. Key considerations include andrographolide content (which can differ significantly between products), extraction methods, the presence or absence of adulterants, and whether the product has undergone independent third-party testing. Some products are standardized to a specified andrographolide content, while others use unstandardized whole-herb preparations — these represent meaningfully different products despite sharing a common label name.
Heavy metal contamination and pesticide residues are considerations for any botanical sourced from agricultural supply chains, and andrographis is no exception. Products carrying third-party certifications from organizations such as USP, NSF, or ConsumerLab provide an additional quality assurance layer. India and China are major production regions, and growing conditions, harvesting practices, and post-harvest handling all influence the final product's composition and purity. Consumers evaluating andrographis supplements benefit from comparing products on the basis of standardization claims, third-party testing, and manufacturer transparency.
FAQs
Is andrographis the same as echinacea? Andrographis and echinacea are entirely different plants from different botanical families and geographic origins. They are sometimes combined in supplement formulations marketed for immune support, which may contribute to confusion between them. Andrographis (Andrographis paniculata) is a tropical Asian herb in the Acanthaceae family, while echinacea species are native to North America and belong to the Asteraceae family.
Can andrographis be used long-term? The available clinical trial data on andrographis generally involves short-term use — typically spanning days to a few weeks — in the context of acute upper respiratory symptoms. Long-term safety data is sparse, and most reference materials do not characterize andrographis as intended for continuous daily consumption. The absence of extended safety data is itself a relevant consideration for anyone contemplating prolonged use.
Does andrographis taste as bitter as its reputation suggests? The plant's common name "king of bitters" is well-earned. Andrographis is among the most intensely bitter botanical preparations encountered in traditional medicine, and this characteristic is attributed in part to its andrographolide content. Capsule and tablet formulations largely bypass the taste experience, while traditional decoction preparations deliver the full sensory profile.
Is there good evidence that andrographis helps with colds? Some clinical trials have reported modest associations between andrographis preparations and cold symptom measures, but systematic reviews characterize the overall evidence as preliminary and limited by methodological constraints. The existing data are considered suggestive by some researchers but insufficient for definitive conclusions. No major Western regulatory body has approved andrographis for any specific health condition.